| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/16/1993 | WO1993016196A3 Myotonic dystrophy |
| 09/16/1993 | WO1993016087A3 Amadori reaction compounds and products, process for their manufacture, and their use |
| 09/16/1993 | WO1993015197A3 Expression of osteogenic factor op-1 in cells of spodoptera frugiperda infected with recombinant baculovirus |
| 09/16/1993 | CA2383007A1 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 09/16/1993 | CA2131995A1 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
| 09/16/1993 | CA2131909A1 Selectively deglycosylated human immunodeficiency virus type i envelope vaccines |
| 09/16/1993 | CA2131898A1 Methods and compositions for the modulation of host immune response to allergens |
| 09/16/1993 | CA2131552A1 Neurotrophic factors having altered receptor binding specificities |
| 09/16/1993 | CA2131444A1 Dna encoding taurine and gaba transporters and uses thereof |
| 09/16/1993 | CA2131389A1 Thrombin receptor antagonists |
| 09/16/1993 | CA2131369A1 Microorganisms having attenuated invasiveness |
| 09/16/1993 | CA2131299A1 Lymphocyte activity regulation by hla peptides |
| 09/16/1993 | CA2131150A1 Receptor complexes with b29 (ig-beta or ig-gamma) and their uses |
| 09/16/1993 | CA2130359A1 Compositions and methods for modulating rna |
| 09/16/1993 | CA2130100A1 Receptor internalization signals |
| 09/16/1993 | CA2130089A1 Protein compound, coding nucleotide sequences, producing cell line and uses thereof |
| 09/16/1993 | CA2126970A1 Insectidal toxins from the parasitic wasp bracon hebetor |
| 09/15/1993 | EP0560409A2 Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation |
| 09/15/1993 | EP0560401A1 Site Selective Genomic Modification of Yeast of the Genus Pichia |
| 09/15/1993 | EP0560156A2 Pseudorabies virus polynucleotids and their use in the production of virus-resistant eucaryotic cells |
| 09/15/1993 | EP0559895A1 Albumin preparation and preservation thereof |
| 09/15/1993 | EP0559834A1 Immunoassay and monoclonal antibodies useful for detecting truncated nerve growth factor receptor |
| 09/15/1993 | EP0559793A1 Hiv protease inhibitors |
| 09/15/1993 | EP0559770A1 Cell stress transcriptional factors |
| 09/15/1993 | EP0559769A1 Heparin binding mitogen with homology to epidermal growth factor (egf) |
| 09/15/1993 | EP0559729A1 Control of plant cell proliferation and growth |
| 09/15/1993 | EP0559725A1 Structural proteins from artificial genes |
| 09/15/1993 | EP0546013A4 Glucagon analogs with asp?9 replacements or deletions |
| 09/15/1993 | EP0457837A4 Stabilization of aqueous-based hydrophobic protein solutions and sustained release vehicle |
| 09/15/1993 | EP0276278B1 Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| 09/15/1993 | CN1076199A 新的肽衍生物 New peptide derivatives |
| 09/15/1993 | CN1022113C Protein and its production method |
| 09/14/1993 | US5245017 Method for isolating CEA-binding protein |
| 09/14/1993 | US5245016 Pseudomonas maltophilia immunoglobulin binding protein and methods for its use |
| 09/14/1993 | US5245014 Method for isolating factors viii from plasma by gel filtration chromatography under group separation conditions |
| 09/14/1993 | US5245013 Acute phase protein modulating endotoxic activity of lipopolysaccharides, assay methods and polypeptides |
| 09/14/1993 | US5245012 Method to achieve solubilization of spider silk proteins |
| 09/14/1993 | US5245011 Cell membranes, DNA coding |
| 09/14/1993 | US5245010 Polypeptide of herpes simplex virus vmw 65 protein |
| 09/14/1993 | US5245009 CRF antagonists |
| 09/14/1993 | US5245008 Process for the purification of insulins by chromatography |
| 09/14/1993 | US5244889 Treatment of cardiovascular disorders |
| 09/14/1993 | US5244882 Porcine growth hormone analogs, and compositions |
| 09/14/1993 | US5244802 Regeneration of cotton |
| 09/14/1993 | US5244797 Having DNA polymerase activity |
| 09/14/1993 | US5244793 TGF-β1/β2: a novel chimeric transforming growth factor-beta |
| 09/14/1993 | US5244792 Preparation of vaccines |
| 09/14/1993 | US5244657 Genetic detoxification of pertussis toxin |
| 09/14/1993 | US5244655 Three chromatographic stages using, as stationary phases, glass particles of controlled porosity, cation exchange resins and resins able to complex heavy metals; human serum albumin as lyophilization protection agent and sugars as stabilizers |
| 09/14/1993 | CA2092674A1 Double transfectants of mhc genes as cellular vaccines for immuno-prevention of tumor metastasis |
| 09/14/1993 | CA2092645A1 Production of recombinant proteins using herpes virus promoters and vp16 transactivators |
| 09/14/1993 | CA2091151A1 Retroviral protease inhibitors |
| 09/14/1993 | CA1322166C Process for the preparation of collagen and obtained product |
| 09/14/1993 | CA1322164C Wound healing |
| 09/14/1993 | CA1322158C Uses of recombinant colony stimulating factor-1 |
| 09/14/1993 | CA1322157C Bifunctional proteins |
| 09/12/1993 | WO1993024632A1 Hybrid siv/hiv-1 viral vectors and monkey model for aids |
| 09/12/1993 | CA2135618A1 Vectors expressing hybrid viruses, methods of use and novel assays |
| 09/09/1993 | DE4206769A1 Analysing host cell shut=off caused by Picorna viruses - by comparing translation prods. of viral 2C gene from RNA with and without cap structure, used e.g. to identify inhibitors of viral 2A protease |
| 09/08/1993 | EP0559632A2 Method of producing tissue factor pathway inhibitor |
| 09/08/1993 | EP0559603A2 Brassica hsp 80 promoter |
| 09/08/1993 | EP0559428A2 Novel polypeptides and DNAs encoding them |
| 09/08/1993 | EP0559234A1 Monoclonal antibodies specific for an epitope in the B chain of platelet-derived growth factor and their use in affinity chromatography |
| 09/08/1993 | EP0559064A2 Complexes containing glycosyl-phosphatidylinositol-proteins and cholanic acid-derivatives, process for their preparation and their use |
| 09/08/1993 | EP0558961A2 Glycopeptide derivatives, process for their manufacture and pharmaceutical compositions comprising them |
| 09/08/1993 | EP0558944A2 RNA and DNA molecules for producing virus resistance |
| 09/08/1993 | EP0558645A1 Erythrocytes and thrombo-erythrocytes as target specific agents |
| 09/08/1993 | EP0558631A1 Recombinant avirulent salmonella antifertility vaccines |
| 09/08/1993 | EP0558491A1 Virus resistance in plants |
| 09/08/1993 | EP0307434B1 Altered antibodies |
| 09/08/1993 | EP0272277B1 EXPRESSION OF HIGHER EUCARYOTIC GENES IN $i(ASPERGILLUS) |
| 09/07/1993 | US5243094 Derivatives of long chain fatty alcohols, their uses, particularly as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing them |
| 09/07/1993 | US5243041 DNA vector with isolated CDNA gene encoding metallopanstimulin |
| 09/07/1993 | US5243040 From blood, immunosorbent |
| 09/07/1993 | US5243038 Gene expression |
| 09/07/1993 | US5243030 Conjugates of a synthetic peptide for diagnosis and prevention of influenza virus infection |
| 09/07/1993 | US5242947 Use of polyamines as ionic-channel regulating agents |
| 09/07/1993 | US5242902 Defensin peptide compositions and methods for their use |
| 09/07/1993 | US5242900 Treatment of diabetes using phosphorylated insulin |
| 09/07/1993 | US5242833 Cholesterol, triglycerides |
| 09/07/1993 | US5242829 Recombinant pseudorabies virus |
| 09/07/1993 | US5242826 Polypeptides for adhering cells to a substrate |
| 09/07/1993 | US5242824 Monoclonal antibody to human carcinomas |
| 09/07/1993 | US5242823 Cloning of the 38kd Mycoplasma hyorhinis regression-associated antigen |
| 09/07/1993 | US5242822 Membrane receptors, beta-adrenergic and serotonin receptors |
| 09/07/1993 | US5242819 DNA molecules encoding hybrid proteins of tissue plasminogen activator and urokinase |
| 09/07/1993 | US5242812 Antigens formed by culture of mammal cells and purification |
| 09/07/1993 | US5242811 Selecting optimal dna sequences to express growth enhancing factor |
| 09/07/1993 | US5242810 Bifunctional inhibitors of thrombin and platelet activation |
| 09/07/1993 | US5242808 Production of bioadhesive precursor protein analogs by genetically engineered organisms |
| 09/07/1993 | US5242798 Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mRNAs, receptors, methods and diagnostics using the same |
| 09/07/1993 | US5242693 Protein curuculin and application of the same |
| 09/07/1993 | US5242692 Anti-metastatic factor |
| 09/07/1993 | US5242691 Purified milk product from animal maintained in hyperimmunized state |
| 09/07/1993 | US5242687 Method of reducing cellular immune response involving T-cells using CD8-bearing antigen presenting cells |
| 09/07/1993 | CA1322079C2 Intermediates useful in the preparation of anf peptide |
| 09/07/1993 | CA1322078C Enzyme inhibitors |
| 09/07/1993 | CA1322077C Process for synthesis of aminomethylene phosphonoalkylphosphinates |
| 09/07/1993 | CA1322075C Flourine containing renin inhibitors |
| 09/07/1993 | CA1321963C Modification of the dna sequence between the shine-dalgarno sequence and the start codon of the trp operon to increase protein expression |